Court Opinion

ID: 9963891
Source: CourtListenerOpinion
Date Created: 2024-04-26 15:03:37.650597+00
Date Added: 2024-06-11T08:25:03.204711
License: Public Domain

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

ROD JARDINE, derivatively, on behalf        )
of HEALTHBOOKPLUS HOLDINGS,                 )
INC.,                                       )
                                            )
             Plaintiff,                     )
                                            )
       v.                                   )   C.A. No. 2023-0672-KSJM
                                            )
CHRISTOPHER TURNER, PANOS                   )
SECHOPOULOUS, AND STATHIS                   )
TOPOUZOGLOU,                                )
                                            )
             Defendants, and                )
                                            )
HEALTHBOOKPLUS HOLDINGS                     )
INC.,                                       )
                                            )
             Nominal Defendant.             )

                 ORDER GRANTING STAY OF PROCEEDINGS

      1.    HealthBrookPlus Holdings, Inc. (“HB+”) is a start-up health technology

company. Its “product is an early identification and guided health platform for

individuals and their families that provides the user with immediate and

personalized health solutions based on the individuals’ needs.”1 The three current

members of the HB+ Board of Directors are Defendants Christopher Turner, Panos

Sechopoulous, and Stathis Topouzoglou (the “Director Defendants”). Each Director

is a founder of HB+.

1 The factual background is drawn from the Verified Derivative Complaint.   See C.A.
2023-0672-KSJM, Docket (“Dkt.”) 1 (“Compl.”) ¶ 9.

                                        1
         2.   Plaintiff Rod Jardine is a current stockholder, former chief technology

officer, and former director of HB+.     In addition, Jardine owns Agile CxO LLC

(“Agile”). On January 9, 2022, HB+ and Agile entered into a contractor agreement

where Agile would provide management consulting services to HB+.

         3.   HB+ is in its pre-revenue phase. As such, it relies heavily on its sales

pipeline projections to raise funds. Turner was in charge of sales pitches and product

sales.    Jardine assisted Turner with these duties.    In November 2022, Jardine

observed that the sales pipeline numbers that Turner was using in his investor

pitches were different from HB+’s internal numbers. Jardine’s complaint gives three

specific examples of these discrepancies.

         4.   In February 2023, in anticipation of a meeting with investors, Turner

sent Jardine a “Business Plan Presentation.” Jardine realized certain information in

the Business Plan Presentation was incorrect and revised it.         Turner rejected

Jardine’s edits.    Jardine called Turner and Sechopoulous and told them the

information in the presentation was incorrect.

         5.   In March 2023, Jardine met with Topouzoglou to discuss the incorrect

information that was shared to investors and potential investors.        Topouzoglou

informed Jardine that he would schedule a meeting of the founders. Instead of a

meeting, on March 21, 2023, Turner told Jardine that HB+ was terminating all of its

agreements with Agile. On April 12, 2023, HB+ informed Jardine that he had been

terminated as an officer and director of HB+ as well.

                                            2
       6.       In addition to allegedly misleading investors and potential investors,

Jardine claims that Turner used corporate assets to fund personal trips. Specifically,

Jardine claims that Turner traveled to Maui, Hawaii at HB+’s expense to visit his

girlfriend, although Turner had told Jardine it was to meet with Maui Health’s CEO.

Additionally, Jardine alleges that Turner and Sechopoulous both used a rental

property in Maui that was either paid for or reimbursed by HB+.

       7.       After HB+ terminated Jardine and Agile, litigation ensued. On April

13, 2023, HB+ filed a lawsuit against Jardine in Colorado federal court alleging

fraudulent inducement, misappropriation of trade secrets, civil theft, and violation of

the federal computer fraud and abuse act.2            On June 13, 2023, Agile filed an

arbitration action in California asserting breach of contract. 3 On June 29, 2023,

Jardine filed this action asserting derivative claims against the Director Defendants.4

       8.       In this action, Jardine asserts three Counts derivatively.

       •        In Count I, for breach of the fiduciary duty of loyalty against the Director
                Defendants, Jardine advances three theories. First, Jardine claims that
                “Turner and Sechopoulous breached their fiduciary duty of loyalty by
                engaging in an illegal scheme to violate federal and state law by
                intentionally causing [HB+] to make false or misleading representations
                during communications with potential investors and solicitations of
                investors, such that expose[d] [HB+] to serious legal liabilities and
                reputational harm.”5 Second, Jardine claims that Turner breached his
                duty of loyalty by engaging in waste of HB+’s assets for his personal
                leisure and entertainment.6 Third, Jardine claims that Turner,

2 Dkt. 16 (“Defs.’ Opening Br.”), Ex. 1.

3 Id., Ex. 3.

4 Dkt. 1.

5 Compl. ¶ 103.

6 Id. ¶ 104.

                                              3
               Sechopoulous, and Topouzoglou breached their duty of loyalty by (a)
               terminating Jardine as CTO in a retaliatory manner, (b) breaching
               HB+’s contract with Agile, (c) permitting Turner to waste corporate
               assets, and (d) failing to follow corporate formalities.7

         •     In Count II, for breach of the fiduciary duty of care against Turner and
               Sechopoulous, Jardine alleges Turner and Sechopoulous were “at least
               grossly negligent in causing [HB+] to make false and misleading
               representations during [their] communications with prospective
               investors.”8 And both “acted grossly negligent[] by failing to make sure
               the represented financial information of [HB+] was correct[.]”9

         •     In Count III, for waste of corporate assets against Turner and
               Sechopoulous, Jardine alleges that Turner spent HB+ money flying to
               Hawaii, California, and New York for non-HB+ related purposes. And
               that Sechopoulous contributed to this misuse by living at a property in
               Maui that Turner rented with HB+ money and that had no business
               purpose.10

         9.    The Director Defendants have moved to dismiss or stay this action.

Their lead argument is that the court should stay or dismiss this action in favor of

the Colorado and California proceedings. They also advance arguments under Court

of Chancery Rules 12(b)(6) and 23.1. Because a stay of proceedings is appropriate,

the court does not reach the Director Defendants’ arguments under Rules 12(b)(6) or

23.1.

         10.   The Director Defendants rely on McWane to argue that a stay or

dismissal is appropriate.11 To be entitled to relief under McWane, a defendant must

7 Id. ¶ 105.

8 Id. ¶¶ 112–13.

9 Id.

10 Id. ¶ 118–19.

11 McWane Cast Iron Pipe Corp. v. McDowell–Wellman Eng’g Co., 263 A.2d 281 (Del.

1970).

                                           4
demonstrate: (i) the existence of “a first-filed prior pending action . . . in another

jurisdiction;” (ii) that the first-filed action “involves similar parties and issues;” and

(iii) that “the court in the other jurisdiction is capable of rendering prompt and

complete justice.”12

      11.    As to the first McWane element, the Director Defendants point to the

Colorado and California proceedings. The Colorado action was filed on April 13. The

California arbitration was filed on June 13. This action was filed on June 29. Both

the Colorado and California proceedings were filed first. Jardine argues that this

sequence lacks legal relevance because the Colorado and California proceedings were

filed within a few months of this action, rendering Delaware “contemporaneously

filed.”13 Generally speaking, the difference of a few hours14 or even a few weeks15

may turn a second-filed action into a contemporaneously filed action for the purposes

of McWane. But the more-than-two-month window between the Colorado action (filed

April 13) and the Delaware action (filed June 29) is not contemporaneous, nor do the

12 Abraham v. D.O.C.-Del. Dep’t of Corrs., 2008 WL 242026, at *1 (Del. Ch. Jan. 24,

2008) (quoting Kaufman v. Kumar, 2007 WL 1765617, at *2 (Del. Ch. 2007)).
13 Dkt. 19 (“Pl.’s Answering Br.”) at 12–13.

14 See, e.g., BP Oil Supply Co. v. ConocoPhillips Co., 2010 WL 702382, at *2 (Del.

Super. Feb. 25, 2010) (“Delaware courts consistently have held that where two suits
are filed mere hours apart, they are considered contemporaneously filed for purposes
of forum non conveniens.” (citing cases)).
15 Zilberstein v. Frankenstein, 2021 WL 5289104, at *4 (Del. Super. Nov. 12, 2021)

(finding two actions filed less than two weeks apart contemporaneously filed).

                                            5
facts    here   warrant    finding   the   California   and   Delaware   actions   to   be

contemporaneous.16 The first element is met.

         12.    As to the second McWane element, the Director Defendants argue that

“there is sufficient overlap and privity among the parties to all of the actions” because

“[a]ll three of these actions involve core allegations of a conspiracy by the Board to

improperly fire Jardine (and terminate Agile’s independent consulting agreement) in

retaliation against him for claiming that Turner engaged in fraudulent misconduct

and to cover-up the same at the Company level.”17 But the parties are different and

the issues only partially overlap. The second element is not fully met.

         13.    The Director Defendants do not make an argument in support of the

third element.18

         14.    Given the dissimilarities in the proceedings, the Colorado and California

proceedings will not resolve all of the claims at issue in this litigation. The claims for

breach of fiduciary duty are unique to this action. For these reasons, McWane is “not

a perfect fit.”19

16 Id. (treating the first-filed and second-filed actions as contemporaneous because

the first-filed action appeared anticipatory, and deeming the actions
contemporaneous had the effect of discouraging a race to the courthouse); In re
Chambers Dev. Co., Inc. S’holders Litig., 1993 WL 179335, at *7 (Del. Ch. May 20,
1993) (noting that whether or not a federal derivative suit filed on April 14, which
was later consolidated with 20 lawsuits filed between March 17 and June 29, was
deemed contemporaneously filed with a Delaware state action filed on April 1, the
Cryo-Maid factors overwhelmingly favored staying the Delaware state action).
17 Defs.’ Opening Br. at 16.

18 See id. at 15–17.

19 Park G.P., Inc. v. CCSB Fin. Corp., 2020 WL 7706962, at *2 (Del. Ch. Dec. 29,

2020).

                                             6
       15.    In the end, however, “[g]ranting a stay is a discretionary enterprise and

derives from a court’s inherent power to control its docket.”20 “A court may grant a

stay ‘on the basis of comity, efficiency, or common sense.’” 21 “A stay of any aspect of

litigation shouldn’t be granted automatically; it should be granted only if the

opponent wouldn’t be prejudiced by the delay and considerations of expense and

litigation economy predominate.”22 “And when resolving whether to stay or not, the

Court ‘must make a particularized judgment evaluating the weight that [purported]

efficiency should be afforded . . . and the significance of any risk of injury to [a party]

. . . that might eventuate from a stay.’”23

       16.    There are good reasons to stay this action in favor of the Colorado and

California proceedings. For one, although the parties and issues in each proceeding

are not identical, they substantially overlap. The parties in all three actions are

closely related. In the Colorado action, HB+ brought suit against Jardine. In the

California action, Jardine’s wholly owned entity Agile brought suit against HB+. And

in the Delaware action, Jardine brought suit derivatively against HB+’s directors.

20 Lima USA, Inc. v. Mahfouz, 2021 WL 5774394, at *7 (Del. Super. Aug. 31, 2021)

(citing Solow v. Aspect Res., LLC, 46 A.3d 1074, 1075 (Del. 2012)).
21 LightLab Imaging, Inc. v. Axsun Techs., Inc., 2012 WL 1764225, at *1 (Del. Ch.

May 10, 2012) (quoting Julian v. Julian, 2009 WL 2937121, at *8 (Del. Ch. Sept. 9,
2009)).
22 Lima USA, 2021 WL 5774394, at *7 (Del. Super. Aug. 31, 2021) (citing Schick, Inc.

v. Amalgamated Clothing & Textile Workers Union, 1987 WL 12450, at *2 (Del. Ch.
June 18, 1987)).
23 Id. (alterations in original) (quoting In re McCrory Parent Corp., 1991 WL 137145,

at *1 (Del. Ch. July 3, 1991)).

                                              7
       17.    As another reason, the proceedings will involve overlapping issues. The

Colorado action concerns Jardine’s alleged fraudulent conduct and seeks rescission of

Jardine’s entire equity interest in HB+. The California action concerns HB+’s alleged

breach of Agile’s contract and seeks monetary relief. The Delaware action concerns

HB+’s directors’ fiduciary breaches and seeks monetary and to-be-determined

equitable relief.

       18.    Whether the Director Defendants retaliated against Jardine will be at

issue in all of these proceedings.24 Here, Jardine claims in part that the Director

Defendants harmed HB+ by wrongfully terminating Jardine and breaching the

contract with Agile, which was “motivated by a desire to punish Jardine” for reporting

Turner       and       Sechopoulous’s          misstatements      and       fraudulent

representations.25 Although the California and Colorado forums could find

retaliation occurred without making factual findings as to an underlying wrongful

fiduciary act, it is likely that the discovery and arguments made in those forums will

overlap with the Delaware action. Given HB+’s allegations, and Jardine’s defenses,

the California and Colorado forums may make findings that would impact the

Delaware action. If allowed to continue simultaneously, that might lead to an

inconsistency, which this court tries to avoid.26

24 See Defs.’ Opening Br., Ex. 2 ¶ 2(c) (Jardine’s answer and affirmative defenses to

the Colorado complaint); id., Ex. 3 ¶¶ 27–28 (California JAMS complaint).
25 Compl. ¶ 104.

26 See Gramercy Emerging Mkts Fund v. Allied Irish Banks, p.l.c., 2016 WL 7494898,

at *8 (Del. Ch. Dec. 30, 2016) (noting that absent a first-filed doctrine, “comity would
                                           8
      19.    For these reasons, a stay in favor of the California and Colorado

proceedings is appropriate.

      20.    The outcome is the same under the six-factor Cryo-Maid test.27 Factors

one (relative ease of access to proof) and two28 (compulsory process) favor Colorado or

California as HB+’s principal place of business is in Colorado, Jardine resides in

California, Turner resides in Colorado, and Sechopoulous and Topouzoglou reside in

Greece.29 Most of the evidence and employees, who might be deposed or called to

testify, are presumably located in Colorado or California, and most likely not located

in Delaware. Factor three (view of the premises) is neutral. Factor four30 (practical

be damaged and inconsistent judicial decisions could result”), aff’d 173 A.3d 1033
(Del. 2017).
27 Gen. Foods Corp. v. Cryo-Maid, Inc., 198 A.2d 681 (Del. 1964); Gramercy Emerging

Mkts. Fund, 173 A.3d at 1036–07 (identifying the six Cryo-Maid factors as: “(1) the
relative ease of access to proof; (2) the availability of compulsory process for
witnesses; (3) the possibility of the view of the premises, if appropriate; (4) all other
practical problems that would make the trial of the case easy, expeditious and
inexpensive; (5) whether or not the controversy is dependent upon the application of
Delaware law which the courts of this State more properly should decide than those
of another jurisdiction; and (6) the pendency or nonpendency of a similar action in
another jurisdiction.” (cleaned up)).
28 Mt. Hawley Ins. Co. v. Jenny Craig, Inc., 668 A.2d 763, 769 (Del. Super. 1995)

(stating that under the second factor, the court evaluates whether “another forum
would provide a substantial improvement as to the number of witnesses who would
be subject to compulsory process” (citation omitted)).
29 As Jardine notes, this court can compel the presence of the Director Defendants,

but presumably this action will involve third-party witnesses most likely located in
either Colorado or California.
30 Martinez v. E.I. DuPont de Nemours & Co., Inc., 86 A.3d 1102, 1104 (Del. 2014)

(stating that under the fourth factor, the court examines “all other practical problems
that would make the trial of the case easy, expeditious and inexpensive” (citation
omitted)).

                                           9
problems) favors Colorado or California because, as with factors one and two,

presumably all the evidence and employees with relative knowledge are located in

those states, and not in Delaware. Factor five (application of Delaware law) favors

Delaware as Delaware law applies. Factor six (pendency or nonpendency of similar

action) favors California or Colorado as similar actions were filed in those states

before the Delaware action was filed. In sum, factors one, two, four, and six favor

either California or Colorado.     Factor five favors Delaware, and factor three is

neutral.    On balance, a stay is warranted in favor of the California and Colorado

proceedings.

      21.      Counsel shall send quarterly reports on the status of the litigation in

California and Colorado. In the meantime, Jardine may seek leave to lift the stay if

events in the parallel proceedings warrant. In all events, the parties shall update the

court of the status of the parallel proceedings at the end of each quarter, with the

first report to be filed at the end of September.

                                         /s/ Kathaleen St. J. McCormick
                                         Chancellor Kathaleen St. J. McCormick
                                         Dated: April 25, 2024

                                           10